Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriersDICK, Michelle G; VERSMOLD, Beatrix; KAST, Karin et al.International journal of cancer (Print). 2012, Vol 130, Num 6, pp 1314-1318, issn 0020-7136, 5 p.Article

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneMEINDL, Alfons; HELLEBRAND, Heide; RAMSER, Juliane et al.Nature genetics. 2010, Vol 42, Num 5, pp 410-414, issn 1061-4036, 5 p.Article

A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal womenTCHATCHOU, Sandrine; JUNG, Anke; DITSCH, Nina et al.Carcinogenesis (New York. Print). 2009, Vol 30, Num 1, pp 59-64, issn 0143-3334, 6 p.Article

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers : Results from a Combined Analysis of 19 StudiesANTONIOU, Antonis C; SINILNIKOVA, Olga M; COUPIER, Isabelle et al.American journal of human genetics. 2007, Vol 81, Num 6, pp 1186-1200, issn 0002-9297, 15 p.Article

Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancerAN YOU; FOKAS, Emmanouil; WANG, Lin-Fang et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 4, pp 621-627, issn 0171-5216, 7 p.Article

A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer riskRONGXI YANG; SCHLEHE, Bettina; ARNOLD, Norbert et al.Breast cancer research and treatment. 2010, Vol 121, Num 3, pp 693-702, issn 0167-6806, 10 p.Article

SNPs in ultraconserved elements and familial breast cancer riskRONGXI YANG; FRANK, Bernd; WEBER, Bernhard H. F et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 2, pp 351-355, issn 0143-3334, 5 p.Article

Comparison of gene expression data from human and mouse breast cancers : Identification of a conserved breast tumor gene setKLEIN, Andreas; WESSEL, Ralf; SEITZ, Susanne et al.International journal of cancer. 2007, Vol 121, Num 3, pp 683-688, issn 0020-7136, 6 p.Article

Limited relevance of the CHEK2 gene in hereditary breast cancerDUFAULT, Michael R; BETZ, Beate; VON LINDERN, Celia et al.International journal of cancer. 2004, Vol 110, Num 3, pp 320-325, issn 0020-7136, 6 p.Article

Genetic variants within miR-126 and miR-335 are not associated with breast cancer riskRONGXI YANG; DICK, Michelle; SCHOTT, Sarah et al.Breast cancer research and treatment. 2011, Vol 127, Num 2, pp 549-554, issn 0167-6806, 6 p.Article

Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machineryGLAESER, Michael; NIEDERACHER, Dieter; DJAHANSOUZI, Sirus et al.Anticancer research. 2006, Vol 26, Num 1B, pp 735-744, issn 0250-7005, 10 p.Article

Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancerWIRTENBERGER, Michael; TCHATCHOU, Sandrine; WEBER, Bernhard H. F et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 11, pp 2201-2208, issn 0143-3334, 8 p.Article

In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cellsDALL, Peter; HERRMANN, Isabell; DURST, Bettina et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 1, pp 51-60, issn 0340-7004, 10 p.Article

C/t polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart disease and myocardial infarctionJIANG, Hong; KLEIN, Rolf Michael; GÜLKER, Hartmut et al.International journal of cardiology. 2002, Vol 84, Num 2-3, pp 171-177, issn 0167-5273Article

Resistance to cd95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 geneMÜSCHEN, Markus; RE, Daniel; BETZ, Beate et al.International journal of cancer. 2001, Vol 92, Num 2, pp 309-310, issn 0020-7136Article

DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladderFLORL, Andrea R; FRANKE, Knut H; NIEDERACHER, Dieter et al.Laboratory investigation. 2000, Vol 80, Num 10, pp 1513-1522, issn 0023-6837Article

Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical managementHEIDEMANN, Simone; FISCHER, Christine; JONAT, Waiter et al.Breast cancer research and treatment. 2012, Vol 134, Num 3, pp 1229-1239, issn 0167-6806, 11 p.Article

A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer riskFURU WANG; ZHIBIN HU; MEINDL, Alfons et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 769-775, issn 0167-6806, 7 p.Article

Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersENGEL, Christoph; VERSMOLD, Beatrix; GARETH EVANS, D et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 11, pp 2859-2868, issn 1055-9965, 10 p.Article

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersANTONIOU, Antonis C; SPURDLE, Amanda B; HOFMANN, Wera et al.American journal of human genetics. 2008, Vol 82, Num 4, pp 937-948, issn 0002-9297, 12 p.Article

Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancerVERSMOLD, Beatrix; FELSBERG, Jörg; PIETSCH, Torsten et al.International journal of cancer. 2007, Vol 121, Num 3, pp 547-554, issn 0020-7136, 8 p.Article

The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancerWIRTENBERGER, Michael; SCHMUTZHARD, Julia; NIEDERACHER, Dieter et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 2, pp 423-426, issn 0143-3334, 4 p.Article

Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancerWIRTENBERGER, Michael; FRANK, Bernd; NIEDERACHER, Dieter et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 8, pp 1655-1660, issn 0143-3334, 6 p.Article